Gilles Wandeler
Inselspital, Bern, Switzerland · Insel Gruppe AG, University Hospital Bern · University of Bern, Switzerland.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gilles Wandeler as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:48 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06037564 · B-free Multistage TrialInsel Gruppe AG, University Hospital Bern · enrolling by invitation · HIV, Drug Resistance, Drug Drug Interaction · principal investigator
- N/ANCT04984772 · Prospective Cohort of HIV/HBV-coinfected Patients in EuropeInsel Gruppe AG, University Hospital Bern · enrolling by invitation · HIV Infections, Hepatitis B, Coinfection · study chair
- Ph2NCT03115736 · TAF for HIV-HBV With Renal DysfunctionInsel Gruppe AG, University Hospital Bern · completed · HIV and Hepatitis B Coinfection · study chair
- N/ANCT02699736 · EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVCopenhagen University Hospital, Rigshospitalet · enrolling by invitation · HIV, Hepatitis B, Hepatitis C · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.U01AI069924 · NIAID · UNIVERSITAT BERN · fiscal years 2024 to 2026 · $1,649,716 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:48 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.Clin Infect Dis · 202357 citationsRCR 6.8
- 30 citationsRCR 1.8
- On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study.J Viral Hepat · 201818 citationsRCR 0.8
- Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study.Eur J Clin Invest · 20157 citationsRCR 0.3
- Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial.Br J Clin Pharmacol · 20212 citationsRCR 0.2
- Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial.Open Forum Infect Dis · 20242 citationsRCR 0.3
- Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial.Swiss Med Wkly · 20241 citationsRCR 0.1